Become A Member
Faculty interested in becoming a member should contact the Research Program Leader(s) of a specific group (mentioned below) and send them his or her completed application and supporting documentation. Upon review, the Program Leader will forward the application package to the Membership Committee for final review and approval.
Research Programs
Research Programs supported by the CCSG are critical to the success of the NYUCI. Research Programs meet full NCI guidelines, including benchmarks for competitively funded research and highly interactive, multi-investigator projects. All Cancer Institute members belong to one of the eight of the Scientific Research Programs and are eligible to join up to two. Below are the Research Programs open for membership.
Disease-Based Research Programs
|
Melanoma |
||
|
Breast Cancer |
||
|
Genitourinary |
Basic Science-Based Research Programs
|
Cancer Immunology |
||
|
Growth Control |
||
|
Stem Cell Biology |
Population-Based Research Programs
|
Environmental and Molecular Carcinogenesis |
||
|
Epidemiology & Cancer Control |
Disease Management Groups
In addition to the Research Programs, members are also encouraged to attend meetings of the Disease Management Groups (DMGs) that focus on clinical issues related to the full spectrum of human cancers. The DMGs are critical to the research mission of the NYUCI. Their purpose is to ensure multidisciplinary care, prioritize disease specific clinical research protocols and most importantly serve as incubators for investigator-initiated clinical and translational research studies. All DMGs are linked to one or more of the CCSG Research Programs.
The multidisciplinary DMG teams meet regularly to plan, prioritize, and successfully implement disease or organ-specific protocols, as well as develop systems for banking human samples. DMGs may meet as more classic multidisciplinary "Tumor Boards," with an additional focus on translational research. Active involvement of more basic scientists is encouraged since these investigators can appreciate the challenges of diagnosis and effective therapy. Involvement in a DMG is not required for NYU Cancer Institute membership, however, it is encouraged.
|
Breast Cancer |
||
|
Endocrine Cancer |
||
|
Gastrointestinal Cancer |
||
|
Genitourinary Cancer (Prostate, Bladder, & Kidney) |
||
|
Gynocologic Cancers |
||
|
Head and Neck Cancer |
||
|
Hematological Malignancies |
||
|
Melanoma |
||
|
Neuro-Oncology (Brain & Spinal Cord Cancers) |
||
|
Pediatric Cancers |
||
|
Phase I Clinical Trials |
||
|
Sarcoma Oncology |
||
|
Thoracic Oncology |



